In vitro activity of Tigecycline and comparators against multidrug resistant Acinetobacter species in Asia: 2004 - 2011
Year: 2012
Type: article
Abstract: Background: Acinetobacter spp. are a frequent cause of nosocomial as well as community-acquired infections and represent increasingly difficult therapeutic challenges. The Tigecycline Evaluation Surveillance Trial (TEST) is monitoring global resistance patterns of significant pathogens, including multidrug resistant (MDR) Acinetobacter spp.
Institution: Pfizer (United States)
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,900
OpenAlex ID: W1965207885